Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.430
+0.050 (2.10%)
At close: Feb 18, 2026, 4:00 PM EST
2.470
+0.040 (1.65%)
After-hours: Feb 18, 2026, 7:00 PM EST

Annovis Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
646919211014252
Market Cap Growth
-4.15%-63.84%75.03%-23.01%174.06%-
Enterprise Value
5157186789543
Last Close Price
2.385.0318.7013.4317.587.54
PB Ratio
3.657.46-24.763.873.206.89
P/TBV Ratio
5.067.46-3.873.206.89
Net Debt / Equity Ratio
-1.16-1.130.74-1.00-1.03-1.07
Quick Ratio
4.092.721.353.6930.3313.96
Current Ratio
4.603.592.394.6830.5414.04
Return on Equity (ROE)
-246.14%-3159.09%-546.40%-69.57%-55.68%-180.82%
Return on Assets (ROA)
-105.88%-138.26%-121.77%-38.88%-33.58%-89.86%
Return on Capital Employed (ROCE)
-198.60%-265.80%-759.60%-90.10%-32.70%-88.10%
Earnings Yield
-37.41%-35.43%-29.29%-23.10%-10.17%-10.51%
Buyback Yield / Dilution
-61.36%-35.60%-10.55%-7.03%-20.88%-2132.36%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q